Clinical Trials

194 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT07217938 2026-03-03

TRADstat

Phase 1/2 Not yet recruiting

48 enrolled

Head & Neck

Deglutition Disorders, Head and Neck Neoplasms

NCT07435584 2026-02-27

EVER-RECODE

38 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07292207 2025-12-18

ARCHE

Phase 2 Not yet recruiting

30 enrolled

Breast Neoplasms

NCT03043924 2025-12-11

MRI-PCOS

Phase NA Completed

52 enrolled

Polycystic Ovary Syndrome

NCT04456920 2025-12-02

BIO-PSY

Phase NA Completed

193 enrolled 19 charts

Breast Neoplasms

NCT05559164 2025-11-14

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

60 enrolled

Breast Neoplasms, Cardiotoxicity

NCT07025005 2025-11-04

VRd MM Fibrate

Phase 4 Recruiting

44 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT06041204 2025-09-03

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Phase NA Recruiting

200 enrolled

Infertility, Female, Polycystic Ovary Syndrome

NCT06033092 2025-08-28

TOLERANT

200 enrolled

Phase 3 Active not recruiting

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT04055493 2025-08-26

ADAPTcycle

1,684 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT05316467 2025-08-11

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Phase 2/3 Recruiting

89 enrolled

GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT07042711 2025-06-29

Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients

300 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT06150898 2025-06-13

KePreSt

112 enrolled

BreastOther

Breast Neoplasms, Inflammation, Obesity

NCT06140108 2025-05-14

Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

Phase 2/3 Completed

70 enrolled

Polycystic Ovary Syndrome, Weight Gain

NCT04789057 2025-05-08

Captain

Phase 4 Recruiting

460 enrolled

Smoking, Pulmonary Disease, Chronic Obstructive

NCT05247268 2025-04-06

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

104 enrolled

Gynecologic

Endometrial Neoplasms

NCT02852486 2025-03-30

EDI-PIO

MyeloidOther hematologic neoplasm

31 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

Phase EARLY_PHASE1 Not yet recruiting

56 enrolled

CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

NCT04717700 2025-03-18

SABLe

50 enrolled

Plasma cell

Multiple Myeloma

NCT04722575 2025-03-13

NEO-TIM

95 enrolled

Dermatologic

Melanoma

NCT06275919 2025-03-13

MIRAGE

104 enrolled

CNS

Meningioma

NCT04503694 2025-03-05

REGINA

Phase 3 Not yet recruiting

72 enrolled

Gastrointestinal

Rectal Neoplasms

NCT06774885 2025-01-14

ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

120 enrolled

Breast Neoplasms, Hot Flashes

NCT04233034 2024-11-27

CLVer

Phase 3 Completed

113 enrolled 42 charts

Phase EARLY_PHASE1 Recruiting

Diabetes Mellitus, Leukemia, Hairy Cell

NCT06643221 2024-10-16

Allo-X

100 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity

NCT04554459 2024-08-14

Pona-CELL

Phase 2 Terminated

4 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05163106 2024-08-02

NEOLETRIB

85 enrolled

Breast Neoplasms

NCT05265988 2024-07-31

MERIDIAN

32 enrolled

Genitourinary

Prostatic Neoplasms

NCT04243122 2024-05-29

AIRPORT-MPN

Classical hematologyMyeloid

44 enrolled

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT06229067 2024-01-29

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

Phase 2 Not yet recruiting

182 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05370807 2023-10-24

RegoMel

Phase 2 Unknown

48 enrolled

Dermatologic

Melanoma

NCT05951309 2023-07-19

Myoinositol Treatment and Asprosin Levels in PCOS

Phase NA Completed

30 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Arachnodactyly

NCT05909293 2023-06-18

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

Phase NA Recruiting

100 enrolled

Phase EARLY_PHASE1 Withdrawn

Leukemia, Myeloid, Acute

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

Genitourinary

Insulin Resistance, Prostatic Neoplasms

NCT05840068 2023-05-03

IGF Level in Breast Cancer Patients Treated With Metformin

Phase 4 Completed

107 enrolled

Breast Neoplasms

NCT05330377 2023-04-25

GM-CLAG in Relapsed/Refractory FLT3-mutated AML

Phase 1 Withdrawn

Recurrence, Leukemia, Myeloid, Acute

NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Phase NA Withdrawn

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT03086538 2022-06-15

Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy

29 enrolled

Gastrointestinal

Colonic Neoplasms

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Phase 2 Suspended

170 enrolled

Breast Neoplasms

NCT04389073 2022-02-25

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

Phase 2 Unknown

138 enrolled

Breast Neoplasms

NCT03027557 2021-05-25

DENOCINA

Phase 3 Completed

46 enrolled 49 charts

Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT04870502 2021-05-03

Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance

Phase 2/3 Completed

161 enrolled

Polycystic Ovary Syndrome

NCT04772846 2021-02-26

Chloroquine for Glioblastoma.

Phase 1/2 Unknown

60 enrolled

CNS

Glioblastoma

NCT04601116 2021-01-14

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Phase 3 Recruiting

3,360 enrolled

Breast Neoplasms

NCT01827930 2020-12-31

MIM

Phase 3 Terminated

68 enrolled 13 charts

Leukemia, Myeloid, Chronic-Phase

NCT04434404 2020-06-16

Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy

Phase 4 Completed

83 enrolled

Breast Neoplasms, Cardiotoxicity

NCT03448731 2020-04-08

DERMIA